Welltower [WELL] vs Healthpeak [DOC] Detailed Stock Comparison
Welltower
NYSE
Loading...
Healthpeak
NYSE
Loading...
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: Welltower wins in 12 metrics, Healthpeak wins in 7 metrics, with 0 ties. Welltower appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Welltower | Healthpeak | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 97.79 | 80.71 | Healthpeak |
| Price-to-Book Ratio | 3.24 | 1.70 | Healthpeak |
| Debt-to-Equity Ratio | 47.36 | 109.01 | Welltower |
| PEG Ratio | 10.27 | -1.06 | Healthpeak |
| EV/EBITDA | 37.64 | 15.42 | Healthpeak |
| Profit Margin (TTM) | 12.18% | 5.90% | Welltower |
| Operating Margin (TTM) | 18.66% | 17.90% | Welltower |
| EBITDA Margin (TTM) | 18.66% | 17.90% | Welltower |
| Return on Equity | 3.45% | 2.14% | Welltower |
| Return on Assets (TTM) | 1.92% | 1.53% | Welltower |
| Free Cash Flow (TTM) | $2.20B | $1.07B | Welltower |
| Dividend Yield | 1.31% | N/A | N/A |
| 1-Year Return | 39.41% | -13.43% | Welltower |
| Price-to-Sales Ratio (TTM) | 12.62 | 4.81 | Healthpeak |
| Enterprise Value | $130.61B | $23.38B | Welltower |
| EV/Revenue Ratio | 14.08 | 8.36 | Healthpeak |
| Gross Profit Margin (TTM) | 39.80% | 60.22% | Healthpeak |
| Revenue per Share (TTM) | $15 | $4 | Welltower |
| Earnings per Share (Diluted) | $1.79 | $0.24 | Welltower |
| Beta (Stock Volatility) | 0.91 | 1.07 | Welltower |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
Welltower vs Healthpeak Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Welltower | -0.26% | 0.08% | 4.55% | 14.58% | 14.83% | 40.35% |
| Healthpeak | 0.99% | 2.27% | 9.25% | 6.31% | -0.46% | -3.92% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Welltower | 39.41% | 198.70% | 210.85% | 152.73% | 259.35% | 386.22% |
| Healthpeak | -13.43% | 37.47% | 4.99% | 21.13% | 66.52% | 66.52% |
Performance & Financial Health Analysis: Welltower vs Healthpeak
| Metric | WELL | DOC |
|---|---|---|
| Market Information | ||
| Market Cap | $117.07B | $13.46B |
| Market Cap Category | Large cap | Large cap |
| 10 Day Avg. Volume | 3,257,030 | 6,317,439 |
| 90 Day Avg. Volume | 3,289,080 | 6,656,890 |
| Last Close | $175.04 | $19.37 |
| 52 Week Range | $122.34 - $180.40 | $16.63 - $23.26 |
| % from 52W High | -2.97% | -16.72% |
| All-Time High | $180.40 (Oct 01, 2025) | $23.26 (Oct 21, 2024) |
| % from All-Time High | -2.97% | -16.72% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.40% | 0.00% |
| Quarterly Earnings Growth | 0.19% | -0.78% |
| Financial Health | ||
| Profit Margin (TTM) | 0.12% | 0.06% |
| Operating Margin (TTM) | 0.19% | 0.18% |
| Return on Equity (TTM) | 0.03% | 0.02% |
| Debt to Equity (MRQ) | 47.36 | 109.01 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | $53.98 | $11.41 |
| Cash per Share (MRQ) | $6.59 | $0.14 |
| Operating Cash Flow (TTM) | $2.61B | $1.24B |
| Levered Free Cash Flow (TTM) | $2.07B | $651.28M |
| Dividends | ||
| Last 12-Month Dividend Yield | 1.31% | N/A |
| Last 12-Month Dividend | $2.01 | N/A |
Valuation & Enterprise Metrics Analysis: Welltower vs Healthpeak
| Metric | WELL | DOC |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 97.79 | 80.71 |
| Forward P/E | 96.18 | 77.48 |
| PEG Ratio | 10.27 | -1.06 |
| Price to Sales (TTM) | 12.62 | 4.81 |
| Price to Book (MRQ) | 3.24 | 1.70 |
| Market Capitalization | ||
| Market Capitalization | $117.07B | $13.46B |
| Enterprise Value | $130.61B | $23.38B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 14.08 | 8.36 |
| Enterprise to EBITDA | 37.64 | 15.42 |
| Risk & Other Metrics | ||
| Beta | 0.91 | 1.07 |
| Book Value per Share (MRQ) | $53.98 | $11.41 |
Financial Statements Comparison: Welltower vs Healthpeak
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | WELL | DOC |
|---|---|---|
| Revenue/Sales | $2.39B | $702.89M |
| Cost of Goods Sold | $1.46B | $273.14M |
| Gross Profit | $926.20M | $429.75M |
| Research & Development | N/A | N/A |
| Operating Income (EBIT) | $378.58M | $135.08M |
| EBITDA | $898.66M | $397.50M |
| Pre-Tax Income | $198.71M | $54.29M |
| Income Tax | $-5.52M | $2.08M |
| Net Income (Profit) | $257.27M | $50.06M |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | WELL | DOC |
|---|---|---|
| Cash & Equivalents | $3.50B | $70.63M |
| Total Current Assets | $7.19B | $913.88M |
| Total Current Liabilities | $1.70B | $834.22M |
| Long-Term Debt | $17.01B | $9.02B |
| Total Shareholders Equity | $34.58B | $8.84B |
| Retained Earnings | $-8.40B | N/A |
| Property, Plant & Equipment | $0 | $422.02M |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | WELL | DOC |
|---|---|---|
| Operating Cash Flow | $699.61M | $297.47M |
| Capital Expenditures | N/A | N/A |
| Free Cash Flow | $587.44M | $279.43M |
| Debt Repayment | $-134.28M | $-4.62B |
| Common Stock Repurchase | N/A | $-24.96M |
Short Interest & Institutional Ownership Analysis
| Metric | WELL | DOC |
|---|---|---|
| Shares Short | 12.28M | 15.89M |
| Short Ratio | 5.61 | 2.52 |
| Short % of Float | 0.02% | 0.03% |
| Average Daily Volume (10 Day) | 3,257,030 | 6,317,439 |
| Average Daily Volume (90 Day) | 3,289,080 | 6,656,890 |
| Shares Outstanding | 635.29M | 699.49M |
| Float Shares | 667.92M | 692.05M |
| % Held by Insiders | 0.00% | 0.00% |
| % Held by Institutions | 0.99% | 0.96% |
Dividend Analysis & Yield Comparison: Welltower vs Healthpeak
| Metric | WELL | DOC |
|---|---|---|
| Last 12-Month Dividend | $2.01 | N/A |
| Last 12-Month Dividend Yield | 1.31% | N/A |
| 3-Year Avg Annual Dividend | $2.09 | N/A |
| 3-Year Avg Dividend Yield | 0.68% | N/A |
| 3-Year Total Dividends | $6.28 | N/A |
| Ex-Dividend Date | Feb 25, 2025 | N/A |